United States · Biotechnology startup
United States · Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Funding reportedLast round: Post ipo equity
What company datasets say Axcella raised
Funding, as reported
Reported in all$186Min dollars
Rounds6
Last roundPost ipo equity
Last round dateOct 2022
Investors listed5
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Axcella in front of investors. Or tell us what we have wrong.